Segluromet (ertugliflozin/metformin hydrochloride)
pCPA File Number:
21099
Negotiation Status:
Concluded without agreement
Indication(s):
Diabetes Mellitus, Type 2
Sponsor/Manufacturer:
Merck Canada Inc.
CDA-AMC Project Number:
SR0566-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: